American Journal of Cardiology
Volume 103, Issue 2 , Pages 175-180, 15 January 2009

Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])

  • Joel M. Gore, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 508-856-3871; fax: 508-856-4571
  • ,
  • Frederick A. Spencer, MD

      Affiliations

    • McMaster University, Hamilton, Ontario, Canada
  • ,
  • Enrique P. Gurfinkel, MD

      Affiliations

    • ICYCC Favaloro Foundation, Buenos Aires, Argentina
  • ,
  • José López-Sendón, MD

      Affiliations

    • Hospital Universitario LePaz, Madrid, Spain
  • ,
  • Ph. Gabriel Steg, MD

      Affiliations

    • INSERM U-698 and Université Paris VII Hôpital Bichat-Claude Bernard, AP-HP, Paris, France
  • ,
  • Christopher B. Granger, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
  • ,
  • Gordon FitzGerald, PhD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Massachusetts
  • ,
  • Giancarlo Agnelli, MD

      Affiliations

    • Department of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy
  • ,
  • GRACE Investigators

Received 11 July 2008; received in revised form 22 August 2008; accepted 22 August 2008. published online 13 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The Global Registry of Acute Coronary Events (GRACE) is supported by an unrestricted educational grant from Sanofi-Aventis, Paris, France, to the Center for Outcomes Research, University of Massachusetts Medical School, Worcester, Massachusetts. Dr. Gore was supported by Sanofi-Aventis. Dr. Gurfinkel was supported by research/other grants from Sanofi-Aventis, Eli Lilly, Pasteur, and Schering; is on the Speakers' Bureau of Bristol-Myers Squibb; and a Consultant/Advisory Board member of the TIMI Group and Sanofi-Aventis. Dr. López-Sendón was supported by research grants from the TIMI Group, Sanofi-Aventis, Servier, BMS, and Amgem; received honoraria from Servier, Novartis, and Pfizer; and is a Consultant/Advisory Board member for Servier, Medtronic, Lilly, and CVT. Dr. Steg was supported by a research grant from Sanofi-Aventis; is on the Speakers Bureau for Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Nycomed, Sanofi-Aventis, Sankyo, Servier, and ZLB-Behring; and is a Consultant/Advisory Board member of AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Sanofi-Aventis, Servier, and Takeda. Dr. Granger was supported by Alexion, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, deCODE Genetics, Genentech, GlaxoSmithKline, Novartis, Proctor & Gamble, Sanofi-Aventis, The Medicines Company, INO Therapeutics, and Medicure. Giancarlo Agnelli was supported by Sanofi-Aventis.

PII: S0002-9149(08)01515-4

doi:10.1016/j.amjcard.2008.08.055

American Journal of Cardiology
Volume 103, Issue 2 , Pages 175-180, 15 January 2009